Cargando…

The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state

Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is a lipid ligand-inducible transcription factor with established metabolic functions, whereas its anti-inflammatory function is poorly understood. To address this issue, we determined the global PPARβ/δ-regulated signaling network in human mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adhikary, Till, Wortmann, Annika, Schumann, Tim, Finkernagel, Florian, Lieber, Sonja, Roth, Katrin, Toth, Philipp M., Diederich, Wibke E., Nist, Andrea, Stiewe, Thorsten, Kleinesudeik, Lara, Reinartz, Silke, Müller-Brüsselbach, Sabine, Müller, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446423/ https://www.ncbi.nlm.nih.gov/pubmed/25934804 http://dx.doi.org/10.1093/nar/gkv331

Ejemplares similares

Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment
por: Schumann, Tim, et al.
Publicado: (2015)

Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients
por: Adhikary, Till, et al.
Publicado: (2017)

The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization
por: Finkernagel, Florian, et al.
Publicado: (2016)

Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
por: Adhikary, T, et al.
Publicado: (2013)

Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling
por: Stockert, Josefine, et al.
Publicado: (2011)

Chromatin Binding of c-REL and p65 Is Not Limiting for Macrophage IL12B Transcription During Immediate Suppression by Ovarian Carcinoma Ascites
por: Unger, Annika, et al.
Publicado: (2018)

A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome
por: Reinartz, Silke, et al.
Publicado: (2016)

The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis
por: Ojasalu, Kaire, et al.
Publicado: (2023)

Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ)
por: Adhikary, Till, et al.
Publicado: (2011)

Proteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment
por: Worzfeld, Thomas, et al.
Publicado: (2018)

The multicellular signalling network of ovarian cancer metastases
por: Sommerfeld, Leah, et al.
Publicado: (2021)

Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
por: Reinartz, Silke, et al.
Publicado: (2014)

Prostacyclin Released by Cancer-Associated Fibroblasts Promotes Immunosuppressive and Pro-Metastatic Macrophage Polarization in the Ovarian Cancer Microenvironment
por: Sommerfeld, Leah, et al.
Publicado: (2022)

Regulation of Cell Proliferation and Differentiation by PPARβ/δ
por: Müller, Rolf, et al.
Publicado: (2008)

PPARβ/δ recruits NCOR and regulates transcription reinitiation of ANGPTL4
por: Legrand, Nathalie, et al.
Publicado: (2019)

Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK‐STAT signaling in macrophages by perturbing lipid raft structures
por: Hammoud, Mohamad K., et al.
Publicado: (2022)

Activation of Cilia-Independent Hedgehog/GLI1 Signaling as a Novel Concept for Neuroblastoma Therapy
por: Koeniger, Anke, et al.
Publicado: (2021)

Cell type‐selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment
por: Reinartz, Silke, et al.
Publicado: (2018)

Basal cell adhesion molecule promotes metastasis‐associated processes in ovarian cancer
por: Sivakumar, Suresh, et al.
Publicado: (2023)

Regulation of TAK1/TAB1-Mediated IL-1β Signaling by Cytoplasmic PPARβ/δ
por: Stockert, Josefine, et al.
Publicado: (2013)

Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment
por: Koeniger, Anke, et al.
Publicado: (2023)

A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis
por: Müller, Rolf, et al.
Publicado: (2008)

Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion
por: Ojasalu, Kaire, et al.
Publicado: (2020)

Phosphoproteomics identify arachidonic-acid-regulated signal transduction pathways modulating macrophage functions with implications for ovarian cancer
por: Dietze, Raimund, et al.
Publicado: (2021)

A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype
por: Rohnalter, Verena, et al.
Publicado: (2015)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

MGA, L3MBTL2 and E2F6 determine genomic binding of the non-canonical Polycomb repressive complex PRC1.6
por: Stielow, Bastian, et al.
Publicado: (2018)

Prognosis of ovarian cancer is associated with effector memory CD8(+) T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells
por: Lieber, Sonja, et al.
Publicado: (2018)

Zinc Finger Independent Genome-Wide Binding of Sp2 Potentiates Recruitment of Histone-Fold Protein Nf-y Distinguishing It from Sp1 and Sp3
por: Völkel, Sara, et al.
Publicado: (2015)

Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6
por: Altieri, Paola, et al.
Publicado: (2012)

The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
por: Worzfeld, Thomas, et al.
Publicado: (2017)

PPAR-δ agonist affects adipo-chondrogenic differentiation of human mesenchymal stem cells through the expression of PPAR-γ
por: Kim, Dong Hyun, et al.
Publicado: (2020)

Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C
por: Steitz, Anna Mary, et al.
Publicado: (2020)

NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
por: Mackenzie, Gerardo G., et al.
Publicado: (2008)

Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1
por: Feld, Christine, et al.
Publicado: (2018)

Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone
por: Wang, Xue-Jiao, et al.
Publicado: (2014)

Effects of the PPAR-β/δ agonist GW0742 during resuscitated porcine septic shock
por: Wepler, Martin, et al.
Publicado: (2013)

TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion
por: Steitz, Anna Mary, et al.
Publicado: (2023)

PPAR-δ in Vascular Pathophysiology
por: Wang, Nanping
Publicado: (2008)

A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice
por: Chen, Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g76uom33fa0sq4e8jgms48f4v4